|
1
|
Klemperer P and Rabin C: Primary neoplasms
of the pleura. A report of five cases. Am J Ind Med. 22:1–31. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stout AP and Murray MR:
Hemangiopericytoma: A vascular tumor featuring zimmermann's
pericytes. Ann Surg. 116:26–33. 1942. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Doyle LA: Sarcoma classification: An
update based on the 2013 World Health Organization Classification
of Tumors of Soft Tissue and Bone. Cancer. 120:1763–1774. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Koch M, Nielsen GP and Yoon SS: Malignant
tumors of blood vessels: Angiosarcomas, hemangioendotheliomas, and
hemangioperictyomas. J Surg Oncol. 97:321–329. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fareed MM, Al Amro AS, Akasha R, Al Assiry
M, Al Asiri M, Tonio M and Bayoumi Y: Parapharyngeal space
hemangiopericytoma treated with surgery and postoperative
radiation-a case report. Head Neck Oncol. 4:102012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Smith RM, Hassan A and Robertson CE: Numb
chin syndrome. Curr Pain Headache Rep. 19:442015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Buchanan G: Two rare tumours involving the
infratemporal fossa: Alveolar soft part sarcoma and
haemangiopericytoma. J Laryngol Otol. 89:375–389. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kanazawa T, Nishino H, Miyata M, Kuriki K,
Abe K and Ichimura K: Haemangiopericytoma of infratemporal fossa. J
Laryngol Otol. 115:77–79. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Brucoli M, Giarda M, Valente G and Benech
A: Hemangiopericytoma of the infratemporal fossa: Progression
toward malignancy in a 30-year history. J Craniofac Surg.
16:1146–1150. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bianchi B, Poli T, Bertolini F and Sesenna
E: Malignant hemangiopericytoma of the infratemporal fossa: Report
of a case. J Oral Maxillofac Surg. 60:309–312. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Penel N, Amela EY, Decanter G, Robin YM
and Marec-Berard P: Solitary fibrous tumors and so-called
hemangiopericytoma. Sarcoma. 2012:6902512012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ambrosini-Spaltro A and Eusebi V:
Meningeal hemangiopericytomas and hemangiopericytoma/solitary
fibrous tumors of extracranial soft tissues: A comparison. Virchows
Arch. 456:343–354. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fletcher CD, Bridge J and Lee J: World
Health Organization Classification of Tumours of Soft Tissue and
Bone. IARC Press; Lyon, France: 2013
|
|
14
|
Koscielny S, Bräuer B and Förster G:
Hemangiopericytoma: A rare head and neck tumor. Eur Arch
Otorhinolaryngol. 260:450–453. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schirmer CM and Heilman CB:
Hemangiopericytomas of the skull base. Neurosurg Focus. 30:E102011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Park MS, Ravi V, Conley A, Patel SR, Trent
JC, Lev DC, Lazar AJ, Wang WL, Benjamin RS and Araujo DM: The role
of chemotherapy in advanced solitary fibrous tumors: A
retrospective analysis. Clin Sarcoma Res. 3:72013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park MS, Patel SR, Ludwig JA, Trent JC,
Conrad CA, Lazar AJ, Wang WL, Boonsirikamchai P, Choi H, Wang X, et
al: Activity of temozolomide and bevacizumab in the treatment of
locally advanced, recurrent, and metastatic hemangiopericytoma and
malignant solitary fibrous tumor. Cancer. 117:4939–4947. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stacchiotti S, Negri T, Palassini E, Conca
E, Gronchi A, Morosi C, Messina A, Pastorino U, Pierotti MA, Casali
PG and Pilotti S: Sunitinib malate and figitumumab in solitary
fibrous tumor: Patterns and molecular bases of tumor response. Mol
Cancer Ther. 9:1286–1297. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Domont J, Massard C, Lassau N, Armand JP,
Le Cesne A and Soria JC: Hemangiopericytoma and antiangiogenic
therapy: Clinical benefit of antiangiogenic therapy (sorafenib and
sunitinib) in relapsed malignant haemangioperyctoma/solitary
fibrous tumour. Invest New Drugs. 28:199–202. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sleijfer S, Ray-Coquard I, Papai Z, Le
Cesne A, Scurr M, Schöffski P, Collin F, Pandite L, Marreaud S, De
Brauwer A, et al: Pazopanib, a multikinase angiogenesis inhibitor,
in patients with relapsed or refractory advanced soft tissue
sarcoma: A phase II study from the European organisation for
research and treatment of cancer-soft tissue and bone sarcoma group
(EORTC study 62043). J Clin Oncol. 27:3126–3132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Quek R, Wang Q, Morgan JA, Shapiro GI,
Butrynski JE, Ramaiya N, Huftalen T, Jederlinic N, Manola J, Wagner
AJ, et al: Combination mTOR and IGF-1R inhibition: Phase I trial of
everolimus and figitumumab in patients with advanced sarcomas and
other solid tumors. Clin Cancer Res. 17:871–879. 2011. View Article : Google Scholar : PubMed/NCBI
|
